These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
    Author: Boer K, Deufel T, Schmidt D, Streck S, Kiehntopf M.
    Journal: Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616.
    Abstract:
    OBJECTIVES: Evaluation of the performance of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 analyzer. DESIGN AND METHODS: Imprecision studies were performed and patient samples were assayed by EMIT assay and by LC-MS/MS. RESULTS: Limit of quantification was established at 2.8 microg/L. A positive bias of 17.5% between results measured on EMIT and on LC-MS/MS was detected. CONCLUSIONS: EMIT 2000 Tacrolimus assay is suitable for automated analyses of Tacrolimus on the Architect c8000.
    [Abstract] [Full Text] [Related] [New Search]